journal article·2026-05-08Open access

Direct Chemical Reprogramming of Human Fibroblasts into Retinal Progenitor-like Cells for Ocular Delivery

Yueh-Chang Lee, Pei-Lun Lai, Chien-Ying Lai, Fang-Ling Chang, Shang-Yen Wu, Po-Yu Lin, Chi-Hsuan Chuang, Yu-Xin Chou, Zhao-Feng Chen, Yu-Cheng Wu, Chih-Lun Cheng, Hsuan Lin, Chi-Hou Ng, Shang-Chih Yang, Jean Lu, Rong-Kung Tsai

Abstract

Direct chemical reprogramming provides a potentially scalable approach for generating retinal lineage-associated cells without genetic manipulation. In this study, human Tenon’s capsule fibroblasts were converted into retinal progenitor-like cells using a defined small-molecule cocktail. Retinal lineage-associated features were evaluated by immunofluorescence staining, quantitative reverse-transcription PCR, Western blot analysis, and bulk RNA sequencing, showing upregulation of neural and retinal markers, including VSX2, and transcriptomic remodeling consistent with transcriptional features associated with neuronal differentiation programs. Functional responsiveness was assessed by glutamate-evoked intracellular calcium imaging, revealing glutamate-responsive intracellular calcium dynamics in induced cells but not in parental fibroblasts. For in vivo assessment, induced cells were delivered via intravitreal transplantation in Wistar rats and subretinal transplantation in Long–Evans rats. One month after transplantation, structural and functional evaluations using optical coherence tomography, electroretinography, and histological analyses showed localized alterations in retinal structure at the subretinal injection site, while no significant differences were observed in scotopic ERG responses under the present experimental conditions. In contrast, fibroblast transplantation showed more prominent structural alterations under similar conditions. Human nuclei-positive signals were detectable in a subset of eyes, exhibiting focal and heterogeneous distribution within retinal regions at the one-month endpoint. Collectively, these suggest the induction of retinal lineage-associated molecular and functional features, with short-term functional tolerability observed in vivo under the present experimental conditions.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Retinal Development and Disorders · Neuroscience and Neural Engineering · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Doctoral Degree Program in Translational Medicine, Tzu Chi University and Academia Sinica, Hualien 970374, Taiwan

Department of Ophthalmology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan

Genomics Research Center, Academia Sinica, Taipei 115201, Taiwan

Biomedical Translation Research Center, Academia Sinica, Taipei 115201, Taiwan

Research Center for Applied Sciences, Academia Sinica, Taipei 115201, Taiwan

Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106319, Taiwan

Institute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan

Institute of Medical Sciences, Tzu Chi University, Hualien 970374, Taiwan

Funding

Academia Sinica · National Science and Technology Council · Hualien Tzu Chi Hospital

References (53)

Show source-provided references
1. Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs10.2147/OPTH.S365486 ↗
2. The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients10.1016/j.ophtha.2017.01.029 ↗
3. Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review10.1007/s12325-021-02036-7 ↗
4. Retinitis pigmentosa10.1016/S0140-6736(06)69740-7 ↗
5. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis10.1016/j.ophtha.2021.04.027 ↗
6. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis10.1016/S2214-109X(13)70145-1 ↗
7. Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations10.1016/j.preteyeres.2020.100861 ↗
8. The ABCA subclass of mammalian transporters10.1016/S0005-2736(99)00170-4 ↗
9. Stem cell therapy in retinal diseases10.4103/1673-5374.361537 ↗
10. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration10.1038/nbt.4114 ↗
11. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration10.1126/scitranslmed.aao4097 ↗
12. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration10.1056/NEJMoa1608368 ↗
13. Embryonic stem cell trials for macular degeneration: A preliminary report10.1016/S0140-6736(12)60028-2 ↗
14. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: Preliminary results in Asian patients10.1016/j.stemcr.2015.04.005 ↗
15. Sugita, S., Mandai, M., Hirami, Y., Takagi, S., Maeda, T., Fujihara, M., Matsuzaki, M., Yamamoto, M., Iseki, K., and Hayashi, N. (2020). HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration. J. Clin. Med., 9.10.3390/jcm9072217 ↗
16. Efficient generation of retinal progenitor cells from human embryonic stem cells10.1073/pnas.0601990103 ↗
17. Growth kinetics and transplantation of human retinal progenitor cells10.1016/j.exer.2009.03.025 ↗
18. Molecular characterization of human retinal progenitor cells10.1167/iovs.08-3067 ↗
19. Generation and clonal isolation of retinal stem cells from human embryonic stem cells10.1111/j.1460-9568.2012.08123.x ↗
20. Low-oxygen culture conditions extend the multipotent properties of human retinal progenitor cells10.1089/ten.tea.2013.0361 ↗
21. Human retinal progenitor cell transplantation preserves vision10.1074/jbc.M113.513713 ↗
22. c-Kit+ cells isolated from human fetal retinas represent a new population of retinal progenitor cells10.1242/jcs.169086 ↗
23. Efficacy and Safety of Human Retinal Progenitor Cells10.1167/tvst.5.4.6 ↗
24. Experimental Study of the Biological Properties of Human Embryonic Stem Cell-Derived Retinal Progenitor Cells10.1038/srep42363 ↗
25. Combined transplantation of human mesenchymal stem cells and human retinal progenitor cells into the subretinal space of RCS rats10.1038/s41598-017-00241-5 ↗
26. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients10.1186/s13287-017-0661-8 ↗
27. Generation of Retinal Progenitor Cells from Human Induced Pluripotent Stem Cell-Derived Spherical Neural Mass10.1007/s13770-016-0021-2 ↗
28. Sheets of human retinal progenitor transplants improve vision in rats with severe retinal degeneration10.1016/j.exer.2018.05.017 ↗
29. Transplantation of Retinal Progenitor Cells from Optic Cup-Like Structures Differentiated from Human Embryonic Stem Cells In Vitro and In Vivo Generation of Retinal Ganglion-Like Cells10.1089/scd.2018.0076 ↗
30. Organoid-derived C-Kit(+)/SSEA4(−) human retinal progenitor cells promote a protective retinal microenvironment during transplantation in rodents10.1038/s41467-019-08961-0 ↗
31. Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinal Degeneration
32. Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs)10.1155/2021/6655372 ↗
33. Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa10.1186/s13287-022-02828-w ↗
34. Label-free enrichment of human pluripotent stem cell-derived early retinal progenitor cells for cell-based regenerative therapies10.1016/j.stemcr.2023.12.001 ↗
35. (2024, November 11). Safety and Tolerability of hRPC in Retinitis Pigmentosa (hRPCRP), Available online: https://clinicaltrials.gov/study/NCT02464436.
36. (2024, December 20). Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa, Available online: https://clinicaltrials.gov/ct2/show/results/NCT02320812.
37. (2025, January 18). Preliminary Results for the Year Ended 31 March 2022. Available online: https://firstwordpharma.com/story/5481449.
38. jCyte Inc. (2025, January 20). Announces Positive Pre-Phase 3 FDA Type B Meeting and Outlines Plans to Start Pivotal Trial of jCell® for Retinitis Pigmentosa in The Second Half of 2024. Available online: https://www.jcyte.com/news/press/2024-feb-21/.
39. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs10.1038/ncomms5047 ↗
40. IGF-1 Signaling Plays an Important Role in the Formation of Three-Dimensional Laminated Neural Retina and Other Ocular Structures From Human Embryonic Stem Cells10.1002/stem.2023 ↗
41. Recapitulation of Human Retinal Development from Human Pluripotent Stem Cells Generates Transplantable Populations of Cone Photoreceptors10.1016/j.stemcr.2017.07.022 ↗
42. Comparison of human retinal progenitor cells cultured in media with or without serum: In vitro and in vivo characteristics and retinal transplantation
43. Generation of neural progenitor cells by chemical cocktails and hypoxia10.1038/cr.2014.32 ↗
44. Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation10.1016/j.stem.2016.03.020 ↗
45. Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons10.1016/j.stem.2015.06.003 ↗
46. Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules10.1016/j.stem.2015.07.006 ↗
47. Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons10.1016/j.stem.2015.09.012 ↗
48. Lai, P.L., Ng, C.H., Wu, C.H., Lai, C.Y., Schuyler, S.C., Wang, V., Lin, H., Lee, Y.C., Chuang, M.H., and Yang, C.H. (2022). Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model. Cells, 11.10.3390/cells11071091 ↗
49. Chemical reprogramming and transdifferentiation10.1016/j.gde.2017.07.003 ↗
50. Formula G1: Cell cycle in the driver’s seat of stem cell fate determination10.1002/bies.201500187 ↗
51. Direct Lineage Reprogramming for Brain Repair: Breakthroughs and Challenges10.1016/j.molmed.2019.06.006 ↗
52. Response to: Janssen et al., “Human ciliary epithelia do express genes with retinal progenitor cell characteristics in vivo”10.1016/j.exer.2013.12.003 ↗
53. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine10.1007/s12015-019-09900-8 ↗